This new weight loss drug ETF bets big on two of the industry's leading players

  • 📰 NBCDFW
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 63%

News ニュース

日本 最新ニュース,日本 見出し

While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers.

"The ability to have active management to overweight companies that are actually in market producing the drugs and then go down the line to identify those that are in particular phases is powerful," Mazza told CNBC's

Eli Lilly and Novo Nordisk each hold a roughly 20% weighting in the ETF, per Roundhill's website as of Friday. The three next largest positions are In the past year, Eli Lilly is up 90%, while Novo Nordisk has gained 68%, as of Friday's market close. Mazza waived concerns that investors have missed out on the rally, noting the weight loss drug industry is still in its"early days."

"The marketplace has plenty of room for growth with other companies coming in, whether they're with more powerful drugs or with things that actually you don't need to have an injectable." 7 tips for developing digital balance, from happiness experts: ‘Find that happy medium where technology is working for you'with AI. They just have a head start," Mazza said." pivoted to focus on diabetes and weight loss drugs a few years ago, were able to get in market and produce results that are remarkable.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 288. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Commodities and Stocks Are Driving Investment Returns in 2024Stocks Analysis by James Picerno covering: Vanguard Total Stock Market Index Fund ETF Shares, SPDR® Bloomberg High Yield Bond ETF, Vanguard FTSE Emerging Markets Index Fund ETF Shares, SPDR® Bloomberg International Treasury Bond ETF. Read James Picerno's latest article on Investing.
ソース: Investingcom - 🏆 450. / 53 続きを読む »

Ether ETF Speculation Could Weigh on SOL, Wider Altcoin MarketOmkar Godbole is a Co-Managing Editor on CoinDesk's Markets team.
ソース: CoinDesk - 🏆 291. / 63 続きを読む »